These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 33720797)

  • 1. Epidemiology of coronaviruses, genetics, vaccines, and scenario of current pandemic of coronavirus diseases 2019 (COVID-19): a fuzzy set approach.
    Khan FM; Ahmad T; Gulistan M; Chammam W; Khan M; Hui J
    Hum Vaccin Immunother; 2021 May; 17(5):1296-1303. PubMed ID: 33720797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
    Khan M; Adil SF; Alkhathlan HZ; Tahir MN; Saif S; Khan M; Khan ST
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus - A Crippling Affliction to Humans.
    Kaul R; Devi S
    Recent Pat Biotechnol; 2022 Aug; 16(3):226-242. PubMed ID: 35379131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of coronaviruses: an overview of virus-host interactions and pathogenesis.
    Hidalgo P; Valdés M; González RA
    Bol Med Hosp Infant Mex; 2021; 78(1):41-58. PubMed ID: 33661875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2: a new dimension to our understanding of coronaviruses.
    Araf Y; Faruqui NA; Anwar S; Hosen MJ
    Int Microbiol; 2021 Jan; 24(1):19-24. PubMed ID: 33231780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV2 Outbreak: Emergence, transmission and clinical features of human coronaviruses.
    Imran M; Yasmeen R
    J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S710-S713. PubMed ID: 33754539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: WHAT'S NEXT?
    Ponce-de-León A; Dolores Niembro-Ortega M; González-Lara MF
    Rev Invest Clin; 2021; 73(5):329-334. PubMed ID: 34609368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of plithogenic graphs: applications in spreading coronavirus disease (COVID-19) globally.
    Sultana F; Gulistan M; Ali M; Yaqoob N; Khan M; Rashid T; Ahmed T
    J Ambient Intell Humaniz Comput; 2022 Apr; ():1-21. PubMed ID: 35401852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and co-infection characteristics of common human coronaviruses in Shanghai, 2015-2020: a retrospective observational study.
    Kong D; Zheng Y; Hu L; Chen J; Wu H; Teng Z; Zhou Y; Qiu Q; Lu Y; Pan H
    Emerg Microbes Infect; 2021 Dec; 10(1):1660-1668. PubMed ID: 34350810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical supplement - COVID-19 Australia: Epidemiology reporting Last updated 19 January 2021.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2021 Jan; 44():. PubMed ID: 33499798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covid mutations: honest approach needed from politicians and scientists on pandemic outlook.
    Dagli M
    BMJ; 2021 Mar; 372():n656. PubMed ID: 33688056
    [No Abstract]   [Full Text] [Related]  

  • 17. Corona viruses: reaching far beyond the common cold.
    Coerdt KM; Khachemoune A
    Afr Health Sci; 2021 Mar; 21(1):207-213. PubMed ID: 34394299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
    Bennet BM; Wolf J; Laureano R; Sellers RS
    Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
    Fuentes-Prior P
    J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.